BMS’ Karen Costello talks about navigating change and challenges in the rapidly advancing biopharma sector. Karen Costello, the general manager of Bristol Myers Squibb’s (BMS) commercial affiliate in Ireland, has more than 20 years of experience working across Ireland’s pharmaceutical sector, but for her, not knowing what each day will bring is perhaps the most … Read more
Bristol Myers Squibb is acquiring 2seventy bio, a deal that gives the pharmaceutical giant full control over the partnered cancer cell therapy Abecma as that product faces headwinds in a competitive multiple myeloma market. According to deal terms announced Monday night, BMS will pay $5 in cash for each share of 2seventy. That represents a … Read more
Optoma is launching a new home entertainment projector line, the Photon Series, and the first entry, the Photon Go is being previewed at the 2025 Bristol HiFi Show that runs from Friday, Feb 21st through Sunday, Feb 23rd. Overview The Optoma Photon Go is designed for both home and on-the-go entertainment. Although we don’t know … Read more
Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations. Biopharmaceutical giant Bristol Myers Squibb (BMY -1.90%) reported fourth-quarter and full-year 2024 earnings on Thursday, Feb. 6, that topped analysts’ consensus estimates. Adjusted earnings per share (EPS) of $1.67 outperformed the anticipated $1.46 while Q4 revenue surged to $12.3 … Read more